Tag: $Gilead Sciences

The biotech Gilead Sciences raised its earnings guidance Thursday while reporting second quarter results that beat Wall Street expectations, as the company continues to battle back from an early-year slump in its share price.

Gilead GILD +0.57% Sciences recently spent about $30 million to increase its stakes in two biotech stocks.

Gilead Sciences has received a positive response from the European Medicines Agency’s Committee for Medicinal Products for Human Use on an additional indication for the use of its antibody-drug conjugate Trodelvy in certain types of pre-treated breast cancer.